Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03842358 · ClinicalTrials.gov registry record · NA
Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 298
- Enrollment target
NCT03842358 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 298 participants.
The verdict
NCT03842358, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
Study Summary
Ultrasound-guided diffuse optical tomography (DOT) has demonstrated its potential role in differentiating malignant and benign breast abnormalities and in predicting and monitoring the neoadjuvant chemotherapy (NAC) response of breast cancer. This unique approach employs a commercial ultrasound (US) transducer and near infrared (NIR) optical imaging sensors mounted on a hand-held US probe. The co-registered US is used for lesion localization, and optical sensors are used for imaging tumor related vascularity.
Interventions
- DEVICE Hand-held hybrid probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2024-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03842358
The ClinicalTrials.gov registry entry for NCT03842358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hand-held hybrid probe is the first listed.
NCT03842358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03842358 about?
NCT03842358 is a clinical study titled "Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography". Ultrasound-guided diffuse optical tomography (DOT) has demonstrated its potential role in differentiating malignant and benign breast abnormalities and in predicting and monitoring the neoadjuvant chemotherapy (NAC) response of breast cancer. This unique approach employs a commercial ultrasound (US)...
What is the current status of trial NCT03842358?
This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2019-03-05. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT03842358?
The interventions under investigation include: Hand-held hybrid probe (DEVICE).
Who is sponsoring clinical trial NCT03842358?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.